Mylan Labs Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MYLAN LABS LTD
MYLAN LABS LTD has sixty-seven approved drugs.
There are seven tentative approvals on MYLAN LABS LTD drugs.
Summary for Mylan Labs Ltd
| US Patents: | 0 |
| Tradenames: | 54 |
| Ingredients: | 52 |
| NDAs: | 67 |
Drugs and US Patents for Mylan Labs Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Labs Ltd | LOPINAVIR AND RITONAVIR | lopinavir; ritonavir | TABLET;ORAL | 079074-002 | Feb 7, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mylan Labs Ltd | GEMCITABINE HYDROCHLORIDE | gemcitabine hydrochloride | INJECTABLE;INJECTION | 205242-001 | Dec 6, 2017 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mylan Labs Ltd | LEUCOVORIN CALCIUM PRESERVATIVE FREE | leucovorin calcium | INJECTABLE;INJECTION | 203800-001 | May 19, 2017 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
